Alpha-interferon for relapsed non-Hodgkin's lymphoma [2]

Bone Marrow Transplantation

Volumn 38, Issue 10, 2006, Pages 701-702

  Armitage, A E ^a   Armitage, J D ^a   Armitage, J O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MITOXANTRONE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AVASCULAR NECROSIS; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; DEPRESSION; DRUG DOSE REGIMEN; FEMALE; HUMAN; HYPOTHYROIDISM; LETTER; MAINTENANCE THERAPY; MALE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SALVAGE THERAPY; T CELL LYMPHOMA; T LYMPHOCYTE;

ADULT; FEMALE; HUMANS; INTERFERON TYPE I, RECOMBINANT; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; RECURRENCE; SALVAGE THERAPY;

EID: 33750534595     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705509     Document Type: Letter

References (6)

1. Vaishampayan U, Karanes C, Du W, Varterasian M, al-Katib A. Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantation. Cancer Invest 2002; 20: 303-310.
2. Vose JM, Bierman PJ, Anderson JR, Kessinger A, Pierson J, Nelson J et al. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: Clinical course and patient follow-up. Blood 1992; 80: 2142-2148.
3. Jonasch E, Haluska FG. Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities. Oncologist 2001; 6: 34-55.
4. Armitage JO, Coiffier B. Activity of interferon-alpha in relapsed patients with diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma. Ann Oncol 2000; 11: 1-3.
5. Reichenberg A, Gorman JM, Dieterich DT. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: A 72 week prospective study. Aids 2005; 19 (Suppl 3): S174-S178.
6. Trask PC, Paterson AG, Esper P, Pau J, Redman B. Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psychooncology 2004; 13: 526-536.